Regulatory woes continue for Biocon. The United States Foods and Drug Administration (USFDA) issued a form 483 with 10 observations to the Bangalore plant.
first published: Aug 4, 2017 08:31 am
A collection of the most-viewed Moneycontrol videos.

Live: Nifty snaps 4-day winning streak but rises 1% this week | Closing Bell

Live: Can Bihar poll outcome trigger Nifty to reclaim 26,000-mark? | Opening Bell

Live: Nifty holds above 25,900 but off nearly 100 pts from day's high | Closing Bell

Live: Will Nifty reclaim 26,000-mark amid record low inflation in Oct? | Opening Bell
You are already a Moneycontrol Pro user.

